Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,301–1,320 of 17,937 drug recalls

Drug Recall Ongoing Historical recordClass III

Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20

by West-Ward Columbus Inc

Reason
Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.
Recall initiated
December 19, 2024
Reported by FDA
January 15, 2025
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

by FDC Limited

Reason
Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Recall initiated
December 16, 2024
Reported by FDA
January 15, 2025
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-309-02 (carton), NDC #: 49884-309-52 (blisters).

by ENDO USA, Inc.

Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Recall initiated
November 18, 2024
Reported by FDA
January 15, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-307-02 (carton), NDC #: 49884-307-52 (blisters).

by ENDO USA, Inc.

Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Recall initiated
November 18, 2024
Reported by FDA
January 15, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters).

by ENDO USA, Inc.

Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Recall initiated
November 18, 2024
Reported by FDA
January 15, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cards containing 6 tablets each, Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-310-02 (carton), NDC#: 49884-310-52 (blisters).

by ENDO USA, Inc.

Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Recall initiated
November 18, 2024
Reported by FDA
January 15, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Nhan Sam Tuyet Lien Truy Phong Hoan, Capsules, 30-Count Bottles, Manufactured by Yee Hong Pharmaceuticals, SDN, Penang, Malasia.

by Buy-Herbal

Reason
Marketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine
Recall initiated
December 12, 2024
Reported by FDA
January 15, 2025
Distribution
U.S Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass III

Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-678-15

by AvKARE

Reason
LABELING: LABEL MIX-UP
Recall initiated
December 18, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by: AvKARE, Pulaski, TN, 38478, NDC 50268-068-15.

by AvKARE

Reason
LABELING: LABEL MIX-UP
Recall initiated
December 18, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

by Hikma Injectables USA Inc

Reason
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Recall initiated
December 19, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25

by Hikma Injectables USA Inc

Reason
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Recall initiated
December 19, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

by VIONA PHARMACEUTICALS INC

Reason
Crystallization
Recall initiated
December 10, 2024
Reported by FDA
January 8, 2025
Distribution
US Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

by VIONA PHARMACEUTICALS INC

Reason
Crystallization
Recall initiated
December 10, 2024
Reported by FDA
January 8, 2025
Distribution
US Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

FORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottles

by GNMart LLC

Reason
Marketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.
Recall initiated
December 12, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01

by SOMERSET THERAPEUTICS LLC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
December 16, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.

by AvKARE

Reason
Failed Dissolution Specifications
Recall initiated
December 4, 2024
Reported by FDA
January 8, 2025
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

by Lupin Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Recall initiated
December 20, 2024
Reported by FDA
January 8, 2025
Distribution
One US distributor in Ohio.

View recall →

Drug Recall Ongoing Historical recordClass II

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

by MXBBB

Reason
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Recall initiated
November 14, 2024
Reported by FDA
January 1, 2025
Distribution
Product was sold via Amazon Marketplace.

View recall →

Drug Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

by RemedyRePack Inc.

Reason
CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
Recall initiated
December 2, 2024
Reported by FDA
January 1, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass II

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40

by Curium US, LLC

Reason
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
Recall initiated
November 26, 2024
Reported by FDA
January 1, 2025
Distribution
Nationwide USA and Canada.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.